Sunday, October 15, 2017 12:39:27 AM
2. Our auditors have expressed substantial doubt about our ability to continue as a going concern
3. We entered into a royalty and licensing agreement with Chaya Hendrick, our CEO, which requires substantial payments by us on an annual basis and additionally in the event gross revenues are derived, which could harm our financial position.
4. As of June 30, 2017, we owe Chaya Hendrick, our CEO, $520,848 in deferred salary, of which the failure to pay could result in Chaya Hendrick’s termination of employment, the result of which would materially harm our business.
5. Additionally, there can be no assurances that Chaya would not attempt to foreclose on our assets in order to satisfy such debt obligations.
6. “In particular, our current strategy to penetrate the market for contactless logical access identification and transaction solutions is heavily dependent on the vision, leadership and experience of its Chairman and CEO, C. Hendrick.”
7. We do not have effective internal controls over our financial reporting
8. Our board of directors has broad discretion to issue additional securities
9. We are authorized under our certificate of incorporation to issue up to 305,000,000 shares consisting of 300,000,000 shares of common stock and 5,000,000 “blank check” shares of preferred stock. Shares of our blank check preferred stock provide the board of directors with broad authority to determine voting, dividend, conversion, and other rights. Our board may generally issue those common and preferred shares, or convertible securities to purchase those shares, without further approval by our shareholders
So according to the SEC filing - no effective controls over internal finance ( but $24 million expended up until now )
Anyhow, looking forward to a contribution from an optimist on this stock-Are there any optimists left?
Recent SMME News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/21/2024 06:41:03 PM
- Credit Card to Prevent Fraudulent Activities • AllPennyStocks.com • 12/21/2023 08:00:00 PM
- Credit Card to Prevent Fraudelent Activities • AllPennyStocks.com • 12/21/2023 08:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 08:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 11:00:48 AM
- Form 253G1 - • Edgar (US Regulatory) • 11/06/2023 04:10:16 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 11/06/2023 05:15:06 AM
- Form 1-A POS - • Edgar (US Regulatory) • 10/20/2023 07:26:28 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 10/19/2023 08:20:09 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 10/18/2023 09:26:13 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 10/16/2023 10:00:11 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:58:03 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/27/2023 07:27:47 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 09/26/2023 11:39:30 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM